Clinical Trials Directory

Trials / Unknown

UnknownNCT03820375

Registry Study for the Observation of Patients With ESUS/Cryptogenic Stroke

Registry Study for the Observation of Patients With ESUS/Cryptogenic Stroke (ESUS = Embolic Stroke of Undetermined Source)

Status
Unknown
Phase
Study type
Observational
Enrollment
750 (estimated)
Sponsor
Ludwig-Maximilians - University of Munich · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

Up to know, there is no clear diagnostic and therapeutic pathway for patients with embolic stroke of undetermined source (ESUS). This prospective registry study, which follows up adult ESUS patients for 36 months, is intended to provide important data for the detection of an individual approach in ESUS patients based on a structured diagnostic and therapeutic pathway.

Detailed description

The open-label, academic, prospective, monocentric, observational registry-study (Catch-up-ESUS registry study) started in 01/2018. All ESUS-patients (≥18 years) treated in our hospital are included and will be followed up for three years. Depending on age (\< 60 years or ≥ 60 years), the patients are processed according to a standardized treatment algorithm designed interdisciplinary by neurologists and cardiologists. An insertable cardiac monitor (ICM) is implanted in all of them by default. Patients \< 60 years without evidence of atrial fibrillation and co-existing PFO are planned for PFO closure within 6 months after stroke.

Conditions

Timeline

Start date
2018-01-01
Primary completion
2023-01-01
Completion
2026-01-01
First posted
2019-01-29
Last updated
2019-01-30

Locations

1 site across 1 country: Germany

Source: ClinicalTrials.gov record NCT03820375. Inclusion in this directory is not an endorsement.